N/A
N=159
Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression
Chronic Pain · Depression
Bottom Line
View on ClinicalTrials.gov: NCT02262377 ↗Enrolled (actual)
159
Serious AEs
1.3%
Results posted
Aug 2019
Primary outcome: Primary: Chronic Pain — 6.0; 6.0; 6.0; 5.0 units on a scale — p=0.68
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Integrative Medicine Group Visits (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston Medical Center
- Primary completion
- Sep 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Chronic Pain |
6.0; 6.0; 6.0; 5.0; 6.0; 6.0 | 0.68 |
| PRIMARY Depression |
9.32; 10.15 | 0.054 |
| PRIMARY Pain Self Efficacy Scale |
34; 38 | 0.98 |
| PRIMARY Pain Medication Use |
49; 60 | — |
| SECONDARY Emergency Department Use |
9; 9 | — |
Summary
The purpose of this study is to determine whether Integrative Medicine Group Visits (IMGV) are effective for treating patients with chronic pain and depression.
Eligibility Criteria
Inclusion Criteria
- self-reported chronic pain for at least 12 weeks
- average pain intensity for the previous week >4 on a 0 to 10 numerical rating scale; PHQ-9 score >5, indicating minor depression or greater
- English fluency sufficient to follow treatment instructions and answer survey questions.
Exclusion Criteria
- previous participation in IMGV
- new pain treatments in past month or anticipated to begin in next 3 months
- active or planned worker's compensation, disability, or personal injury claims
- known or planned pregnancy
- manic symptoms
- active suicidality
- psychotic symptoms
- no PCP
Data sourced from ClinicalTrials.gov (NCT02262377). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.